Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1992 Nov 7;305(6862):1124–1128. doi: 10.1136/bmj.305.6862.1124

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.

J A Kanis 1, O Johnell 1, B Gullberg 1, E Allander 1, G Dilşen 1, C Gennari 1, A A Lopes Vaz 1, G P Lyritis 1, G Mazzuoli 1, L Miravet 1, et al.
PMCID: PMC1883704  PMID: 1463947

Abstract

OBJECTIVE--To examine the effects of taking drugs affecting bone metabolism on the risk of hip fracture in women aged over 50 years. DESIGN--Retrospective, population based, case-control study by questionnaire. SETTING--14 centres in six countries in southern Europe. SUBJECTS--2086 women with hip fracture and 3532 control women matched for age. MAIN OUTCOME MEASURES--Number of drugs affecting bone metabolism taken and length taken for. RESULTS--Women taking drugs affecting bone metabolism had a significantly decreased risk of hip fracture. After adjustment for differences in other risk factors, the relative risk of hip fractures was 0.55 (95% confidence interval 0.31 to 0.85) in women taking oestrogens, 0.75 (0.60 to 0.94) in those taking calcium, and 0.69 (0.51 to 0.92) in those taking calcitonin. The fall in risk was not significant for anabolic steroids (0.6 (0.29 to 1.22)). Neither vitamin D nor fluorides were associated with a significant decrease in the risk of hip fracture. The effect on hip fracture risk increased significantly with increasing duration of exposure (risk ratio 0.8 (0.61 to 1.05) for less than median exposure v 0.66 (0.5 to 0.88) for greater than median exposure). Drugs were equally effective in older and younger women, with the exception of oestrogen. CONCLUSIONS--Oestrogen, calcium, and calcitonins significantly decrease the risk of hip fracture. Short term intervention late in the natural course of osteoporosis may have significant effects on the incidence of hip fracture.

Full text

PDF
1124

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Browner W. S., Seeley D. G., Vogt T. M., Cummings S. R. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet. 1991 Aug 10;338(8763):355–358. doi: 10.1016/0140-6736(91)90489-c. [DOI] [PubMed] [Google Scholar]
  2. Chesnut C. H., 3rd, Ivey J. L., Gruber H. E., Matthews M., Nelp W. B., Sisom K., Baylink D. J. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism. 1983 Jun;32(6):571–580. doi: 10.1016/0026-0495(83)90027-6. [DOI] [PubMed] [Google Scholar]
  3. Cooper C., Barker D. J., Wickham C. Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain. BMJ. 1988 Dec 3;297(6661):1443–1446. doi: 10.1136/bmj.297.6661.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dawson-Hughes B., Dallal G. E., Krall E. A., Harris S., Sokoll L. J., Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med. 1991 Oct 1;115(7):505–512. doi: 10.7326/0003-4819-115-7-505. [DOI] [PubMed] [Google Scholar]
  5. Dequeker J., Tobing L., Rutten V., Geusens P. Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire. Clin Rheumatol. 1991 Mar;10(1):49–53. doi: 10.1007/BF02208033. [DOI] [PubMed] [Google Scholar]
  6. Ettinger B., Genant H. K., Cann C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985 Mar;102(3):319–324. doi: 10.7326/0003-4819-102-3-319. [DOI] [PubMed] [Google Scholar]
  7. Kanis J. A., Geusens P., Christiansen C. Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease. Osteoporos Int. 1991 Jun;1(3):182–188. doi: 10.1007/BF01625451. [DOI] [PubMed] [Google Scholar]
  8. Kanis J. A., Passmore R. Calcium supplementation of the diet--I. BMJ. 1989 Jan 21;298(6667):137–140. doi: 10.1136/bmj.298.6667.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kanis J. A. Treatment of osteoporotic fracture. Lancet. 1984 Jan 7;1(8367):27–33. doi: 10.1016/s0140-6736(84)90191-0. [DOI] [PubMed] [Google Scholar]
  10. Law M. R., Wald N. J., Meade T. W. Strategies for prevention of osteoporosis and hip fracture. BMJ. 1991 Aug 24;303(6800):453–459. doi: 10.1136/bmj.303.6800.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Naessén T., Persson I., Adami H. O., Bergström R., Bergkvist L. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. Ann Intern Med. 1990 Jul 15;113(2):95–103. doi: 10.7326/0003-4819-113-2-95. [DOI] [PubMed] [Google Scholar]
  12. Ott S. M., Chesnut C. H., 3rd Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med. 1989 Feb 15;110(4):267–274. doi: 10.7326/0003-4819-110-4-267. [DOI] [PubMed] [Google Scholar]
  13. Riggs B. L., Hodgson S. F., O'Fallon W. M., Chao E. Y., Wahner H. W., Muhs J. M., Cedel S. L., Melton L. J., 3rd Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med. 1990 Mar 22;322(12):802–809. doi: 10.1056/NEJM199003223221203. [DOI] [PubMed] [Google Scholar]
  14. Storm T., Thamsborg G., Steiniche T., Genant H. K., Sørensen O. H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med. 1990 May 3;322(18):1265–1271. doi: 10.1056/NEJM199005033221803. [DOI] [PubMed] [Google Scholar]
  15. Watts N. B., Harris S. T., Genant H. K., Wasnich R. D., Miller P. D., Jackson R. D., Licata A. A., Ross P., Woodson G. C., 3rd, Yanover M. J. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 1990 Jul 12;323(2):73–79. doi: 10.1056/NEJM199007123230201. [DOI] [PubMed] [Google Scholar]
  16. Weiss N. S., Ure C. L., Ballard J. H., Williams A. R., Daling J. R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980 Nov 20;303(21):1195–1198. doi: 10.1056/NEJM198011203032102. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES